Human NK Cell Education by Inhibitory Receptors for MHC Class I

Slides:



Advertisements
Similar presentations
Volume 15, Issue 8, Pages (May 2016)
Advertisements

Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Volume 2, Issue 10, Pages (October 2015)
Defective natural killer–cell cytotoxic activity in NFKB2-mutated CVID-like disease  Vassilios Lougaris, MD, Giovanna Tabellini, PhD, Massimiliano Vitali,
CD56+/CD16− Natural Killer cells expressing the inflammatory protease granzyme A are enriched in synovial fluid from patients with osteoarthritis  P.
Volume 40, Issue 1, Pages (January 2014)
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.
Volume 31, Issue 5, Pages (November 2009)
Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role.
Rapid, Flow Cytometric Assay for NK Alloreactivity Reveals Exceptions to Rules Governing Alloreactivity  Dianne De Santis, Bree A. Foley, Elisabeth John,
Volume 137, Issue 3, Pages e7 (September 2009)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 7, Issue 6, Pages (December 1997)
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 38, Issue 4, Pages (April 2013)
Lung Natural Helper Cells Are a Critical Source of Th2 Cell-Type Cytokines in Protease Allergen-Induced Airway Inflammation  Timotheus Y.F. Halim, Ramona H.
The IL-17A-Producing CD8+ T-Cell Population in Psoriatic Lesional Skin Comprises Mucosa-Associated Invariant T Cells and Conventional T Cells  Marcel.
IL-13-Stimulated Human Keratinocytes Preferentially Attract CD4+CCR4+ T cells: Possible Role in Atopic Dermatitis  Rahul Purwar, Thomas Werfel, Miriam.
Volume 31, Issue 5, Pages (November 2009)
CD56+/CD16− Natural Killer cells expressing the inflammatory protease granzyme A are enriched in synovial fluid from patients with osteoarthritis  P.
Volume 45, Issue 2, Pages (August 2016)
Volume 45, Issue 2, Pages (August 2016)
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells  Mouldy Sioud,
Volume 28, Issue 5, Pages (May 2008)
Volume 138, Issue 4, Pages (April 2010)
Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome  Caroline Pical-Izard, Roberto.
Expansion of NKG2A−LIR1− Natural Killer Cells in HLA-Matched, Killer Cell Immunoglobulin-Like Receptors/HLA-Ligand Mismatched Patients following Hematopoietic.
Volume 35, Issue 1, Pages (July 2011)
Volume 29, Issue 2, Pages (August 2008)
Volume 42, Issue 3, Pages (March 2015)
Volume 25, Issue 3, Pages (September 2006)
Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype  Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti,
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Volume 33, Issue 1, Pages (July 2010)
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 28, Issue 6, Pages (June 2008)
Volume 31, Issue 5, Pages (November 2009)
Volume 24, Issue 2, Pages (February 2006)
Volume 22, Issue 3, Pages (March 2005)
Volume 15, Issue 5, Pages (May 2016)
Volume 24, Issue 9, Pages (September 2016)
Volume 43, Issue 2, Pages (August 2015)
Volume 29, Issue 6, Pages (December 2008)
Volume 30, Issue 6, Pages (June 2009)
Volume 40, Issue 1, Pages (January 2014)
Volume 38, Issue 1, Pages (January 2013)
Volume 39, Issue 6, Pages (December 2013)
The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor.
Abnormal Natural Killer Cell Function in Systemic Sclerosis: Altered Cytokine Production and Defective Killing Activity  Mayuka Horikawa, Minoru Hasegawa,
Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
Volume 32, Issue 1, Pages (January 2010)
Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T H1 subsets  Martin Willheim,
MHC-Dependent and -Independent Activation of Human Nickel-Specific CD8+ Cytotoxic T Cells from Allergic Donors1  Corinne Moulon, Doris Wild, Hans Ulrich.
Volume 27, Issue 3, Pages (September 2007)
Dysregulation of Lymphocyte Interleukin-12 Receptor Expression in Sézary Syndrome  Mohamed H. Zaki, Ryan B. Shane, Yuemei Geng, Louise C. Showe, Suzanne.
Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses  Julia A. Wagner, Melissa.
Volume 33, Issue 5, Pages (November 2010)
Volume 32, Issue 2, Pages (February 2010)
Volume 32, Issue 6, Pages (June 2010)
Volume 7, Issue 2, Pages (August 1997)
SAP Protein-Dependent Natural Killer T-like Cells Regulate the Development of CD8+ T Cells with Innate Lymphocyte Characteristics  Mihalis Verykokakis,
Volume 28, Issue 5, Pages (May 2008)
Volume 25, Issue 1, Pages (July 2006)
Volume 31, Issue 6, Pages (December 2009)
Volume 22, Issue 3, Pages (March 2005)
Volume 21, Issue 4, Pages (April 2013)
Volume 37, Issue 4, Pages (October 2012)
Volume 25, Issue 4, Pages (October 2006)
Presentation transcript:

Human NK Cell Education by Inhibitory Receptors for MHC Class I Nicolas Anfossi, Pascale André, Sophie Guia, Christine S. Falk, Sophie Roetynck, C. Andrew Stewart, Violette Breso, Coralie Frassati, Denis Reviron, Derek Middleton, François Romagné, Sophie Ugolini, Eric Vivier  Immunity  Volume 25, Issue 2, Pages 331-342 (August 2006) DOI: 10.1016/j.immuni.2006.06.013 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 A Multiparameter Flow Cytometric Assay Reveals the Presence of NK Cell Subsets with Various Functional Capacities (A) PBMC preparations were incubated in the presence or absence of K562 cells for 4 hr at an effector:target ratio of 5:1. Samples were analyzed by flow cytometry and gated on NK cells (CD3−CD56+ lymphocytes). Dot plots of one representative experiment of nine are represented. Numbers indicate the mean percentages of NK cells in each quadrant. (B) PBMC preparations were incubated as in (A) but in the presence of antibody-coated target cells (P815), IL-12 (20 ng/mL), or IL-15 (10 ng/mL). Dot plots of one representative experiment of nine are represented. Numbers indicate the percentages of NK cells in each quadrant. Immunity 2006 25, 331-342DOI: (10.1016/j.immuni.2006.06.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 NK Cells Lacking Surface HLA Class I Receptors Are Hyporesponsive to Tumor Cells and CD16 mAb-Coated Plates (A) Two reciprocal cell subsets were defined within peripheral blood NK cells: KIR−NKG2A− NK cells that do not express KIR2DL1, KIR2DS1, KIR2DL2, KIR2DS2, KIR2DS4, KIR3DL1, or NKG2A, and KIR+NKG2A+ NK cells that express at least one of these receptors. PBMC preparations were incubated as in Figure 1A. Dot plots of one representative experiment of nine are represented. Numbers indicate the mean percentages ± SD of NK cells in each quadrant (n = 9). (B) PBMC preparations were stained with CD3 and CD56 mAb to define NK cells. KIR and NKG2A expression was assessed with a mixture of KIR and NKG2A mAb as in (A). Histograms of one representative experiment of nine are represented. Numbers indicate the mean percentages ± SD of NK cells (n = 9) in corresponding areas. (C) PBMC preparations were stained with CD3 and CD56 mAb to define NK cells. KIR and NKG2A expression was assessed with a mixture of KIR and NKG2A mAb as in (A). CD56bright NK cells were gated out. PBMC preparations were incubated with K562 cells for 4 hr. Results indicate the percentage of reactive NK cells within each NK subset (n = 17). ∗∗∗p < 0.001. Each dot and line represents the results from one individual. Open symbols correspond to KIR−NKG2A− NK cells; closed symbols correspond to the NK cell subset expressing a least one of these MHC class I receptors (KIR+NKG2A+). (D) As in (C), but PBMC preparations were incubated with antibody-coated P815 cells (ADCC) or plate bound CD16 mAb for 4 hr. Results indicate the percentage of reactive NK cells within each NK subset (n = 8); ∗∗p < 0.01; ∗∗∗p < 0.001. Immunity 2006 25, 331-342DOI: (10.1016/j.immuni.2006.06.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Phenotype of Hyporesponsive KIR−NKG2A− NK Cells PBMC preparations were stained as in Figure 2A. Samples were analyzed for the cell-surface expression of indicated cell-surface molecules by flow cytometry. Numbers indicate the % of NK cells in corresponding areas, or the total mean fluorescence intensity for perforin, granzyme B, NKp30, NKp46, CD244, and CD226. Histograms of one representative experiment of three are represented. Immunity 2006 25, 331-342DOI: (10.1016/j.immuni.2006.06.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 Characterization of Hyporesponsive KIR−NKG2A− NK Cells (A) PBMC preparations were incubated in the presence or absence of PMA (1 ng/mL) and ionomycin (0.5 μM) for 4 hr. Histograms indicate the mean percentages ± SD of reactive NK cells within each NK subset (n = 7). (B) As in Figure 2C, but PBMC preparations were incubated for 24 hr with IL-12 (5 ng/mL) and IL-18 (20 ng/mL) in combination. Results indicate the mean percentages ± SD of reactive NK cells within each NK subset (n = 5); ∗p < 0.05. (C) As in Figure 2C, but PBMC preparations were incubated for 24 hr with IL-15 (10 ng/mL) or IL-12 (5 ng/mL) and IL-18 (20 ng/mL) in combination. Cells were washed and incubated for an extra 4 hr with L721.221 cells. Histograms indicate the mean percentage ± SD of reactive cells within each NK subset (n = 5). ∗p < 0.05; ∗∗p < 0.01. Immunity 2006 25, 331-342DOI: (10.1016/j.immuni.2006.06.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 5 Evidence for a Role of Inhibitory KIR and HLA Class I in the Acquisition of NK Cell Function in C2C2 Individuals (A) Top: The KIR genotype (kirotype) of a representative C2C2 KIR2DL1+ donor. Bottom: Gating of the indicated NK cell subsets. (B) PBMC preparations were incubated for 4 hr in the presence of indicated stimuli and analyzed by 6-color flow cytometry. The bars indicate the % of CD107+ or IFN-γ+ cells in the indicated NK cell subsets. The bars corresponding to the NK cell subset that expresses a KIR interacting with self HLA class I are in black. The bars corresponding to the NK cell subset that does not express NKG2A or a KIR interacting with self HLA class I are in white. A representative experiment of seven performed with six other C2C2 individuals is shown. (C) As in (B) for a group of C2C2 donors (n = 7 for K562 stimulation; n = 5 for ADCC and CD16 stimulation), including three donors with no 2DS1 and 2DS2 genes. Each dot and line represents the results from one individual. Open symbols correspond to the NK cell subsets that do not express NKG2A or a KIR interacting with self HLA class I. Closed symbols correspond to the NK cell subset expressing a KIR interacting with self HLA class I. Immunity 2006 25, 331-342DOI: (10.1016/j.immuni.2006.06.013) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 6 Evidence for a Role of Inhibitory KIR and HLA Class I in the Acquisition of NK Cell Function in C1C1 Individuals (A) Top: The KIR genotype (kirotype) of a representative C1C1 KIR2DL2+ donor. Bottom: Gating of the indicated NK cell subsets. (B) PBMC preparations were incubated for 4 hr in the presence of indicated stimuli and analyzed by 6-color flow cytometry. The bars indicate the % of CD107+ or IFN-γ+ cells in the indicated NK cell subsets. The bars corresponding to the NK cell subset that expresses a KIR interacting with self HLA class I are in black. The bars corresponding to the NK cell subset that does not express NKG2A or a KIR interacting with self HLA class I are in white. A representative experiment of seven performed with six other C1C1 individuals is shown. (C) As in Figure 5B for a group of C1C1 donors (n = 7 for K562 stimulation; n = 5 for ADCC and CD16 stimulation), including three donors with no 2DS1 and 2DS2 genes. Each dot and line represents the results from one individual. Open symbols correspond to the NK cell subsets that do not express NKG2A or a KIR interacting with self HLA class I. Closed symbols correspond to the NK cell subset expressing a KIR interacting with self HLA class I. Immunity 2006 25, 331-342DOI: (10.1016/j.immuni.2006.06.013) Copyright © 2006 Elsevier Inc. Terms and Conditions